220 related articles for article (PubMed ID: 19376640)
1. The aflatoxin-induced TP53 mutation at codon 249 (R249S): biomarker of exposure, early detection and target for therapy.
Gouas D; Shi H; Hainaut P
Cancer Lett; 2009 Dec; 286(1):29-37. PubMed ID: 19376640
[TBL] [Abstract][Full Text] [Related]
2. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
[TBL] [Abstract][Full Text] [Related]
3. Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein.
Gouas DA; Shi H; Hautefeuille AH; Ortiz-Cuaran SL; Legros PC; Szymanska KJ; Galy O; Egevad LA; Abedi-Ardekani B; Wiman KG; Hantz O; Caron de Fromentel C; Chemin IA; Hainaut PL
Carcinogenesis; 2010 Aug; 31(8):1475-82. PubMed ID: 20538734
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
[TBL] [Abstract][Full Text] [Related]
5. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.
Hussain SP; Schwank J; Staib F; Wang XW; Harris CC
Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425
[TBL] [Abstract][Full Text] [Related]
6. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.
Kirk GD; Lesi OA; Mendy M; Szymañska K; Whittle H; Goedert JJ; Hainaut P; Montesano R
Oncogene; 2005 Sep; 24(38):5858-67. PubMed ID: 16007211
[TBL] [Abstract][Full Text] [Related]
7. Absence of TP53 codon 249 mutations in young Guinean children with high aflatoxin exposure.
Turner PC; Sylla A; Kuang SY; Marchant CL; Diallo MS; Hall AJ; Groopman JD; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2053-5. PubMed ID: 16103461
[TBL] [Abstract][Full Text] [Related]
8. TP53 and hepatocellular carcinoma.
Puisieux A; Ozturk M
Pathol Biol (Paris); 1997 Dec; 45(10):864-70. PubMed ID: 9769950
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics of high frequency 249 codon mutation of p53 gene in hepatocellular carcinoma in prevalent area of China].
Ming L; Yuan B; Thorgeirsson SS
Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):122-4. PubMed ID: 11776852
[TBL] [Abstract][Full Text] [Related]
10. Ser-249 TP53 and CTNNB1 mutations in circulating free DNA of Egyptian patients with hepatocellular carcinoma versus chronic liver diseases.
Hosny G; Farahat N; Tayel H; Hainaut P
Cancer Lett; 2008 Jun; 264(2):201-8. PubMed ID: 18313840
[TBL] [Abstract][Full Text] [Related]
11. Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients.
Jackson PE; Kuang SY; Wang JB; Strickland PT; Muñoz A; Kensler TW; Qian GS; Groopman JD
Carcinogenesis; 2003 Oct; 24(10):1657-63. PubMed ID: 12869416
[TBL] [Abstract][Full Text] [Related]
12. P53 codon 249 mutation in hepatocellular carcinomas from Nigeria.
Ndububa DA; Yakicier CM; Ojo OS; Adeodu OO; Rotimi O; Ogunbiyi O; Ozturk M
Afr J Med Med Sci; 2001; 30(1-2):125-7. PubMed ID: 14510167
[TBL] [Abstract][Full Text] [Related]
13. Genomic stability prevails in North-African hepatocellular carcinomas.
Pineau P; Ezzikouri S; Marchio A; Benazzouz M; Cordina E; Afifi R; Elkihal L; Khalfallah MT; Mestiri H; Tebbal S; Berkane S; Debzi N; Triki H; Dejean A; Iguer F; Bahri O; Essaid El Feydi AE; Benjelloun S
Dig Liver Dis; 2007 Jul; 39(7):671-7. PubMed ID: 17531558
[TBL] [Abstract][Full Text] [Related]
14. Aflatoxin-induced TP53 R249S mutation in hepatocellular carcinoma in Thailand: association with tumors developing in the absence of liver cirrhosis.
Villar S; Ortiz-Cuaran S; Abedi-Ardekani B; Gouas D; Nogueira da Costa A; Plymoth A; Khuhaprema T; Kalalak A; Sangrajrang S; Friesen MD; Groopman JD; Hainaut P
PLoS One; 2012; 7(6):e37707. PubMed ID: 22675488
[TBL] [Abstract][Full Text] [Related]
15. TP53 and liver carcinogenesis.
Staib F; Hussain SP; Hofseth LJ; Wang XW; Harris CC
Hum Mutat; 2003 Mar; 21(3):201-16. PubMed ID: 12619106
[TBL] [Abstract][Full Text] [Related]
16. A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention.
Wild CP; Montesano R
Cancer Lett; 2009 Dec; 286(1):22-8. PubMed ID: 19345001
[TBL] [Abstract][Full Text] [Related]
17. Exposure biomarkers in chemoprevention studies of liver cancer.
Wild CP; Turner PC
IARC Sci Publ; 2001; 154():215-22. PubMed ID: 11220661
[TBL] [Abstract][Full Text] [Related]
18. p53 mutation in hepatocellular carcinoma after aflatoxin exposure.
Ozturk M
Lancet; 1991 Nov; 338(8779):1356-9. PubMed ID: 1682737
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of electrospray ionization mass spectrometry detection of codon 249 mutations in the p53 gene compared with RFLP.
Qian GS; Kuang SY; He X; Groopman JD; Jackson PE
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1126-9. PubMed ID: 12376521
[TBL] [Abstract][Full Text] [Related]
20. Low Frequency of Aflatoxin Induced TP53 Gene Codon 249 Mutation in Hepatocellular Carcinoma from Egyptian Patients Living in the Nile Delta Region.
Mosbeh A; Abdelmaguid W; Ezzat S; Kohla M; Sultan MM; Abdel-Rahman MH
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3165-3168. PubMed ID: 37774068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
